Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
35
GCO Quote, Financials, Valuation and Earnings
Last price:
$21.53
Seasonality move
:
7.26%
Day range:
$20.74 - $21.85
52-week range:
$20.09 - $44.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
0.45x
Volume:
408.6K
Avg. volume:
315.2K
1-year change:
-12.72%
Market cap:
$244M
Revenue:
$2.3B
EPS (TTM):
-$1.77
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.4B | $2.4B | $2.3B | $2.3B | |
| Revenue Growth (YoY) | -18.69% | 35.58% | -1.54% | -2.53% | 0.02% | |
| Cost of Revenues | $982.1M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $804.5M | $1.2B | $1.1B | $1.1B | $1.1B | |
| Gross Profit Margin | 45.03% | 48.77% | 47.64% | 47.27% | 47.17% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $813.8M | $1B | $1B | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$97.3M | $7.9M | -$1.1M | -$30.8M | -$3.6M | |
| Operating Expenses | $813.8M | $1B | $1B | $1.1B | $1.1B | |
| Operating Income | -$9.3M | $147.5M | $94.1M | $16.8M | $17.2M | |
| Net Interest Expenses | $5.1M | $2.4M | $2.9M | $7.8M | $4.3M | |
| EBT. Incl. Unusual Items | -$111.7M | $153M | $90.1M | -$21.8M | $9.3M | |
| Earnings of Discontinued Ops. | -$401K | -$97K | -$327K | $6.8M | $622K | |
| Income Tax Expense | -$55.6M | $38M | $17.8M | $1.9M | $28.8M | |
| Net Income to Company | -$56.4M | $114.9M | $71.9M | -$16.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$56.4M | $114.9M | $71.9M | -$16.8M | -$18.9M | |
| Basic EPS (Cont. Ops) | -$3.97 | $8.11 | $5.77 | -$1.50 | -$1.74 | |
| Diluted EPS (Cont. Ops) | -$3.97 | $7.92 | $5.66 | -$1.50 | -$1.74 | |
| Weighted Average Basic Share | $14.2M | $14.2M | $12.5M | $11.2M | $10.8M | |
| Weighted Average Diluted Share | $14.2M | $14.5M | $12.7M | $11.2M | $10.8M | |
| EBITDA | -$60.1M | $198.4M | $135.8M | $35.4M | $13.6M | |
| EBIT | -$106.6M | $155.4M | $93M | -$14M | $13.6M | |
| Revenue (Reported) | $1.8B | $2.4B | $2.4B | $2.3B | $2.3B | |
| Operating Income (Reported) | -$9.3M | $147.5M | $94.1M | $16.8M | $17.2M | |
| Operating Income (Adjusted) | -$106.6M | $155.4M | $93M | -$14M | $13.6M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $636.8M | $727.7M | $725M | $739M | $745.9M | |
| Revenue Growth (YoY) | -6.02% | 14.27% | -0.36% | 1.92% | 0.95% | |
| Cost of Revenues | $345M | $371.9M | $388.4M | $396.9M | $396.3M | |
| Gross Profit | $291.8M | $355.8M | $336.6M | $342.1M | $349.6M | |
| Gross Profit Margin | 45.83% | 48.89% | 46.43% | 46.29% | 46.87% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $226.5M | $290.5M | $285.8M | $303.5M | $301.8M | |
| Other Inc / (Exp) | -$2.5M | $18.1M | -$1.1M | -$1.4M | -$1.8M | |
| Operating Expenses | $226.5M | $290.5M | $285.8M | $303.5M | $301.8M | |
| Operating Income | $65.3M | $65.3M | $50.8M | $38.5M | $47.9M | |
| Net Interest Expenses | $912K | $517K | $1.3M | $1.5M | $802K | |
| EBT. Incl. Unusual Items | $61.8M | $82.8M | $48.5M | $35.6M | $45.2M | |
| Earnings of Discontinued Ops. | -$126K | -$58K | -$249K | $6.9M | $828K | |
| Income Tax Expense | -$28.2M | $20.6M | $9.3M | $15.3M | $11.7M | |
| Net Income to Company | $89.9M | $62.1M | $38.9M | $27.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $89.9M | $62.1M | $38.9M | $27.2M | $34.4M | |
| Basic EPS (Cont. Ops) | $6.29 | $4.52 | $3.27 | $2.38 | $3.20 | |
| Diluted EPS (Cont. Ops) | $6.20 | $4.41 | $3.21 | $2.38 | $3.13 | |
| Weighted Average Basic Share | $14.3M | $13.7M | $11.9M | $10.9M | $10.7M | |
| Weighted Average Diluted Share | $14.3M | $14.1M | $12.1M | $10.9M | $11M | |
| EBITDA | $73.4M | $94M | $60.7M | $51.2M | $46M | |
| EBIT | $62.5M | $83.3M | $49.8M | $37.2M | $46M | |
| Revenue (Reported) | $636.8M | $727.7M | $725M | $739M | $745.9M | |
| Operating Income (Reported) | $65.3M | $65.3M | $50.8M | $38.5M | $47.9M | |
| Operating Income (Adjusted) | $62.5M | $83.3M | $49.8M | $37.2M | $46M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.4B | $2.4B | $2.3B | $2.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $982.1M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $804.5M | $1.2B | $1.1B | $1.1B | $1.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $813.8M | $1B | $1B | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$97.3M | $7.9M | -$1.1M | -$30.8M | -$3.6M | |
| Operating Expenses | $813.8M | $1B | $1B | $1.1B | $1.1B | |
| Operating Income | -$9.3M | $147.5M | $94.1M | $16.8M | $17.2M | |
| Net Interest Expenses | $5.1M | $2.4M | $2.9M | $7.8M | $4.3M | |
| EBT. Incl. Unusual Items | -$111.7M | $153M | $90.1M | -$21.8M | $9.3M | |
| Earnings of Discontinued Ops. | -$401K | -$97K | -$327K | $6.8M | $622K | |
| Income Tax Expense | -$55.6M | $38M | $17.8M | $1.9M | $28.8M | |
| Net Income to Company | -$56.4M | $114.9M | $71.9M | -$16.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$56.4M | $114.9M | $71.9M | -$16.8M | -$18.9M | |
| Basic EPS (Cont. Ops) | -$4.08 | $8.20 | $5.93 | -$1.41 | -$1.70 | |
| Diluted EPS (Cont. Ops) | -$4.17 | $8.01 | $5.82 | -$1.41 | -$1.77 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$60.2M | $198.5M | $135.8M | $35.4M | $53M | |
| EBIT | -$106.7M | $155.5M | $93M | -$14M | $13.6M | |
| Revenue (Reported) | $1.8B | $2.4B | $2.4B | $2.3B | $2.3B | |
| Operating Income (Reported) | -$9.3M | $147.5M | $94.1M | $16.8M | $17.2M | |
| Operating Income (Adjusted) | -$106.7M | $155.5M | $93M | -$14M | $13.6M | |
| Period Ending | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.4B | $2.3B | $2.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.2B | $1.2B | $1.2B | -- | |
| Gross Profit | $1.2B | $1.1B | $1.1B | $1.1B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $1B | $1.1B | $1.1B | -- | |
| Other Inc / (Exp) | $7.9M | -$1.1M | -$30.8M | -$3.6M | -- | |
| Operating Expenses | $1B | $1B | $1.1B | $1.1B | -- | |
| Operating Income | $147.5M | $94.1M | $16.8M | $17.2M | -- | |
| Net Interest Expenses | $2.4M | $2.9M | $7.8M | $4.3M | -- | |
| EBT. Incl. Unusual Items | $153M | $90.1M | -$21.8M | $9.3M | -- | |
| Earnings of Discontinued Ops. | -$97K | -$327K | $6.8M | $622K | -- | |
| Income Tax Expense | $38M | $17.8M | $1.9M | $28.8M | -- | |
| Net Income to Company | $114.9M | $71.9M | -$16.8M | -$53.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $114.9M | $71.9M | -$16.8M | -$18.9M | -- | |
| Basic EPS (Cont. Ops) | $8.20 | $5.93 | -$1.41 | -$1.70 | -- | |
| Diluted EPS (Cont. Ops) | $8.01 | $5.82 | -$1.41 | -$1.77 | -- | |
| Weighted Average Basic Share | $56.7M | $49.8M | $45M | $43.3M | -- | |
| Weighted Average Diluted Share | $58M | $50.8M | $45M | $43.6M | -- | |
| EBITDA | $198.5M | $135.8M | $35.4M | $53M | -- | |
| EBIT | $155.5M | $93M | -$14M | $13.6M | -- | |
| Revenue (Reported) | $2.4B | $2.4B | $2.3B | $2.3B | -- | |
| Operating Income (Reported) | $147.5M | $94.1M | $16.8M | $17.2M | -- | |
| Operating Income (Adjusted) | $155.5M | $93M | -$14M | $13.6M | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $215.1M | $320.5M | $48M | $35.2M | $34M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $31.4M | $39.5M | $40.8M | $53.6M | $48.9M | |
| Inventory | $291M | $278.2M | $458M | $379M | $425.2M | |
| Prepaid Expenses | -- | -- | -- | -- | $66M | |
| Other Current Assets | $130.1M | $71.6M | $25.8M | $39.6M | $34.7M | |
| Total Current Assets | $667.6M | $709.8M | $572.7M | $507.4M | $608.8M | |
| Property Plant And Equipment | $829.6M | $760.1M | $704.7M | $677.2M | $666.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $38.6M | $38.6M | $38.1M | $9.6M | -- | |
| Other Intangibles | $30.9M | $29.9M | $27.4M | $27.3M | -- | |
| Other Long-Term Assets | $20.7M | $22.3M | $30.8M | $25.5M | $25.6M | |
| Total Assets | $1.6B | $1.6B | $1.5B | $1.3B | $1.3B | |
| Accounts Payable | $150.4M | $152.5M | $145M | $114.6M | $168.1M | |
| Accrued Expenses | $51.2M | $53.1M | $51.2M | $45M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $173.5M | $145.1M | $134.5M | $129.2M | $124M | |
| Other Current Liabilities | $527K | $491K | $536K | $549K | $87.7M | |
| Total Current Liabilities | $402.9M | $431.7M | $360.8M | $319.5M | $379.8M | |
| Long-Term Debt | $33M | $15.7M | $44.9M | $34.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $959.6M | $849.5M | $758.7M | $788.6M | |
| Common Stock | $16.4M | $15.1M | $13.9M | $12.8M | -- | |
| Other Common Equity Adj | -$35.1M | -$36.4M | -$41.2M | -$39.6M | -- | |
| Common Equity | $565.8M | $601.6M | $606.2M | $570.4M | $547M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $566.8M | $602.5M | $607M | $571.2M | $547M | |
| Total Liabilities and Equity | $1.6B | $1.6B | $1.5B | $1.3B | $1.3B | |
| Cash and Short Terms | $215.1M | $320.5M | $48M | $35.2M | $34M | |
| Total Debt | $33M | $15.7M | $44.9M | $34.7M | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $215.1M | $320.5M | $48M | $35.2M | $34M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $31.4M | $39.5M | $40.8M | $53.6M | $48.9M | |
| Inventory | $291M | $278.2M | $458M | $379M | $425.2M | |
| Prepaid Expenses | -- | -- | -- | -- | $66M | |
| Other Current Assets | $130.1M | $71.6M | $25.8M | $39.6M | $34.7M | |
| Total Current Assets | $667.6M | $709.8M | $572.7M | $507.4M | $608.8M | |
| Property Plant And Equipment | $829.6M | $760.1M | $704.7M | $677.2M | $666.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $38.6M | $38.6M | $38.1M | $9.6M | -- | |
| Other Intangibles | $30.9M | $29.9M | $27.4M | $27.3M | -- | |
| Other Long-Term Assets | $20.7M | $22.3M | $30.8M | $25.5M | $25.6M | |
| Total Assets | $1.6B | $1.6B | $1.5B | $1.3B | $1.3B | |
| Accounts Payable | $150.4M | $152.5M | $145M | $114.6M | $168.1M | |
| Accrued Expenses | $51.2M | $53.1M | $51.2M | $45M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $173.5M | $145.1M | $134.5M | $129.2M | $124M | |
| Other Current Liabilities | $527K | $491K | $536K | $549K | $87.7M | |
| Total Current Liabilities | $402.9M | $431.7M | $360.8M | $319.5M | $379.8M | |
| Long-Term Debt | $33M | $15.7M | $44.9M | $34.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $959.6M | $849.5M | $758.7M | $788.6M | |
| Common Stock | $16.4M | $15.1M | $13.9M | $12.8M | -- | |
| Other Common Equity Adj | -$35.1M | -$36.4M | -$41.2M | -$39.6M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $566.8M | $602.5M | $607M | $571.2M | $547M | |
| Total Liabilities and Equity | $1.6B | $1.6B | $1.5B | $1.3B | $1.3B | |
| Cash and Short Terms | $215.1M | $320.5M | $48M | $35.2M | $34M | |
| Total Debt | $33M | $15.7M | $44.9M | $34.7M | -- | |
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $61.4M | -$56.4M | $114.9M | $71.9M | -$16.8M | |
| Depreciation & Amoritzation | $49.6M | $46.5M | $43M | $42.8M | $49.4M | |
| Stock-Based Compensation | -- | $8.5M | $9.1M | $14M | $14M | |
| Change in Accounts Receivable | $656K | -$4.2M | -$8.3M | -$1.1M | -$13.3M | |
| Change in Inventories | $1.9M | $76.5M | $10.8M | -$183.6M | $80.4M | |
| Cash From Operations | $117.2M | $157.7M | $239.9M | -$164.9M | $94.8M | |
| Capital Expenditures | $29.8M | $24.1M | $53.9M | $59.9M | $60.3M | |
| Cash Acquisitions | $65.2M | -- | -$80K | -- | -- | |
| Cash From Investing | $53.3M | -$24M | -$33.9M | -$59.9M | -$60M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $93.3M | $221.3M | $29.3M | $338.8M | $477.8M | |
| Long-Term Debt Repaid | -$144.5M | -$205.3M | -$46.5M | -$308.8M | -$488.4M | |
| Repurchase of Common Stock | -$190.4M | -- | -$78.1M | -$77.5M | -$32M | |
| Other Financing Activities | -$14.9M | -$19.1M | -$5.9M | $1.9M | -$5M | |
| Cash From Financing | -$256.5M | -$3.2M | -$101.2M | -$45.5M | -$47.6M | |
| Beginning Cash (CF) | $167.4M | $81.4M | $215.1M | $320.5M | $48M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$86M | $130.6M | $104.8M | -$270.3M | -$12.8M | |
| Ending Cash (CF) | $81.4M | $215.1M | $320.5M | $48M | $35.2M | |
| Levered Free Cash Flow | $87.4M | $133.6M | $186M | -$224.8M | $34.5M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.5M | $32.9M | $20.4M | $6.5M | -$18.9M | |
| Depreciation & Amoritzation | $11.3M | $10.6M | $10.7M | $12.3M | $13.1M | |
| Stock-Based Compensation | -- | $2.5M | $3.7M | $3.2M | $3M | |
| Change in Accounts Receivable | $19.4M | -$5.5M | -$6.5M | -$7.3M | $5M | |
| Change in Inventories | -$5.8M | -$13.5M | -$59.9M | -$30.8M | -$72.8M | |
| Cash From Operations | $4.7M | $26.3M | -$19.8M | $1.6M | -$23.1M | |
| Capital Expenditures | $7.5M | $15M | $10.8M | $14.4M | $13.1M | |
| Cash Acquisitions | -$75K | -- | -- | -- | -- | |
| Cash From Investing | -$7.6M | -$15M | -$10.8M | -$14.4M | -$13.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.5M | $1.9M | $145.2M | $121M | $146.7M | |
| Long-Term Debt Repaid | -$168.3M | -$5.6M | -$109M | -$121M | -$123.5M | |
| Repurchase of Common Stock | -- | -$28.5M | -$21.1M | -- | -$440K | |
| Other Financing Activities | -$16.2M | -- | -$67K | -$56K | -- | |
| Cash From Financing | -$181M | -$32.6M | $19.1M | -$1.9M | $23.6M | |
| Beginning Cash (CF) | $299.1M | $304M | $44.9M | $37.4M | $45.9M | |
| Foreign Exchange Rate Adjustment | -$182K | -$74K | -$1.3M | -$970K | $303K | |
| Additions / Reductions | -$183.9M | -$21.2M | -$11.5M | -$14.8M | -$12.6M | |
| Ending Cash (CF) | $115.1M | $282.8M | $32.1M | $21.7M | $33.6M | |
| Levered Free Cash Flow | -$2.8M | $11.4M | -$30.6M | -$12.8M | -$36.2M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$56.4M | $114.9M | $71.9M | -$16.8M | -- | |
| Depreciation & Amoritzation | $46.5M | $43M | $42.8M | $49.4M | -- | |
| Stock-Based Compensation | -- | $9.1M | $14M | $14M | $9.8M | |
| Change in Accounts Receivable | -$4.2M | -$8.3M | -$1.1M | -$13.3M | -- | |
| Change in Inventories | $76.5M | $10.8M | -$183.6M | $80.4M | -- | |
| Cash From Operations | $157.7M | $239.9M | -$164.9M | $94.8M | -- | |
| Capital Expenditures | $24.1M | $53.9M | $59.9M | $60.3M | $27.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$24M | -$33.9M | -$59.9M | -$60M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $221.3M | $29.3M | $338.8M | $477.8M | -- | |
| Long-Term Debt Repaid | -$205.3M | -$46.5M | -$308.8M | -$488.4M | -- | |
| Repurchase of Common Stock | -- | -$78.1M | -$77.5M | -$32M | -- | |
| Other Financing Activities | -$19.1M | -$5.9M | $1.9M | -$5M | -- | |
| Cash From Financing | -$3.2M | -$101.2M | -$45.5M | -$47.6M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $130.6M | $104.8M | -$270.3M | -$12.8M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $133.6M | $186M | -$224.8M | $34.5M | -- | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52.7M | $33M | -$44M | -$53.3M | -- | |
| Depreciation & Amoritzation | $32.3M | $31.9M | $35.4M | $39.5M | -- | |
| Stock-Based Compensation | $6.5M | $10.5M | $11.1M | $9.8M | -- | |
| Change in Accounts Receivable | -$5.5M | -$10.2M | -$17M | $1.4M | -- | |
| Change in Inventories | -$48.1M | -$293.9M | -$61.1M | -$143.6M | -- | |
| Cash From Operations | $152.1M | -$244M | -$23.5M | -$29.1M | -- | |
| Capital Expenditures | $34.5M | $39.8M | $49.7M | $27.4M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$34.4M | -$39.8M | -$49.7M | -$27.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $25.3M | $212.1M | $365.4M | $344.3M | -- | |
| Long-Term Debt Repaid | -$42.9M | -$136.4M | -$282.1M | -$278.8M | -- | |
| Repurchase of Common Stock | -$28.5M | -$77.5M | -$32M | -$9.8M | -- | |
| Other Financing Activities | -$4.1M | -$3.9M | -$2.3M | -$2.1M | -- | |
| Cash From Financing | -$50.7M | -$1.6M | $47.2M | $54.5M | -- | |
| Beginning Cash (CF) | $777.2M | $566.1M | $117.2M | $100.3M | -- | |
| Foreign Exchange Rate Adjustment | $680K | -$3M | -$306K | $384K | -- | |
| Additions / Reductions | $67M | -$285.5M | -$26M | -$2M | -- | |
| Ending Cash (CF) | $844.8M | $277.7M | $90.9M | $98.7M | -- | |
| Levered Free Cash Flow | $117.6M | -$283.8M | -$73.3M | -$56.5M | -- | |
Get GCO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GCO
Sector
P/E ratio
--
16.41x
PEG ratio
-0.48x
0.19x
P/B ratio
0.45x
1.39x
Price / LTM sales
0.10x
0.66x
Growth Metrics
GCO
Sector
Revenue growth
0.95%
1.66%
Earnings growth
31.51%
1.97%
Revenue (5-year growth)
1.14%
3.61%
Earnings forecast
$3.31
$0.30
Profitability
GCO
Sector
Profitability FY 2024
$1.1B
$482.3M
Return on invested capital
-3.16%
4.88%
Return on assets
-1.39%
2.99%
Return on equity
-3.48%
7.37%
Earnings Date
Last Earnings Date
Mar
7
Next Earnings Date
May
30
Estimated Next Earnings Date
Jun
6
Balance Sheet
GCO
Sector
Total cash
$34M
$157.2M
Short term investments
--
$58.4M
Total assets
$1.3B
$1.6B
Long term debt
--
$151.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
